A refined method for the meta-analysis of controlled clinical trials with binary outcome

Statistics in Medicine

Volumn 20, Issue 24, 2001, Pages 3875-3889

  Friede, Tim ^a,c   Kieser, Meinhard ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; PLACEBO;

ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYSPEPSIA; HUMAN; META ANALYSIS; MULTICENTER STUDY; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; VARIANCE;

CISAPRIDE; COMPUTER SIMULATION; DYSPEPSIA; GASTROINTESTINAL AGENTS; HUMANS; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0035977414     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1009     Document Type: Article

References (35)

1. Meta-analysis in clinical trials
2. The combination of estimates from different experiments
3. A likelihood approach to meta-analysis with random effects
4. Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis
5. Estimation of a common mean and weighted means statistics
6. Meta-analysis for dose-response models
7. Bayesian approaches to random effects meta-analysis: A comparative study
8. Estimators for the one-way random effects model with unequal error variances
9. ANOVA and MINQUE type estimators for the one-way random effects model
10. Nonnegative estimation of variance components in an unbalanced one-way random effects model
11. Nonnegative minimum biased invariant estimation in variance component models
12. Geographical differences in the prevalence of dyspepsia
13. Effect of the non-antidopaminergic drug cisapride on post-prandial nausea
14. Non-cholinergic, non-antidopaminergic treatment of chronic digestive symptoms suggestive of a motility disorder: A two-step pilot evaluation of cisapride
15. Cisapride in the treatment of functional non-ulcer dyspepsia
16. Cisapride in the management of chronic functional dyspepsia: A multicenter, double-blind, placebo-controlled study
17. Efficacy of cisapride in patients with non-ulcer dyspepsia. A placebo-controlled study
18. Cisapride in a non-ulcer dyspepsia
19. Relief of epigastric pain in non-ulcer dyspepsia: Controlled trial of the promotility drug cisapride
20. Cisapride treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes
21. Cisapride in chronic dyspepsia: Results of a double-blind, placebo-controlled trial
22. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metocloproamide: A double-blind, placebo-controlled study
23. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia
24. Efficacy of cisapride therapy in functional dyspepsia
25. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: A double-blind placebo-controlled trial
26. Estimation of variance and covariance components in linear models
27. An alternative method for meta-analysis
28. A general parametric approach to the meta-analysis of randomized clinical trials
29. The bias and higher cumulants of the logarithm of a binomial variate
30. On the bias of various estimators of the logit and its variance with application to quantal bioassay
31. The bias of the commonly-used estimate of variance in meta-analysis
32. Some corrections of the significance level in meta-analysis
33. A random-effects regression model for meta-analysis
34. Detecting and describing heterogeneity in meta-analysis
35. Explaining heterogeneity in meta-analysis: A comparison of methods